Lugano, Switzerland / Hong Kong SAR, China, 16 July – The European Society for Medical Oncology (ESMO), which represents a global community of over 40,000 oncology professionals, is proud to announce the inaugural ESMO Targeted Anticancer Therapies (TAT) Asia Congress 2025 , to be held from 18–20 July 2025.
Set against the backdrop of dynamic Hong Kong—rapidly emerging as a key hub for early drug development and biotech innovation—the congress will convene a diverse group of stakeholders, including researchers, clinicians, industry leaders, regulators and policymakers to foster collaboration and accelerate the development of innovative cancer therapies.
The ESMO TAT Asia Congress 2025 is placed to become a catalyst for global collaboration and innovation in oncology, recognising the region’s growing leadership in early drug development and creating new opportunities for cross-border partnerships.
The programme at a glance
The abstracts will be published online as a supplement to ESMO Open and can be viewed through the online programme .
Press accreditation
ESMO welcomes press representatives working for recognised press outlets interested in obtaining information and reporting on cancer issues, upon presentation of a letter of assignment and a valid press card. Press representatives are required to observe and abide by the ESMO Policy on Press Activities and the embargo schedule for ESMO Targeted Anticancer Therapies Asia Congress 2025. To apply for press accreditation, please fill out the form available here .
Third Parties Media registration
Third Parties Media representatives and Filming Crews not eligible as press must abide by the ESMO Policy on Media Activities Organised by Third Parties and can request a Third Parties Media badge through registration@esmo.org (Cc media@esmo.org ).
Further information
ESMO Press Office
press@esmo.org
Notes to editors
Please make sure to use the official name of the meeting in your reports: ESMO Targeted Anticancer Therapies Asia Congress 2025 and the official congress hashtag #ESMOTATAsia25. Follow it to stay up to date and use it to take part in the conversation on X , LinkedIn, Bluesky , Instagram, Facebook, YouTube, WeChat.
About the European Society for Medical Oncology (ESMO)
Representing more than 40,000 oncology professionals from 179 countries and territories, ESMO is a reference for oncology education and information. Driven by a shared determination to secure the best possible outcomes for patients, ESMO is committed to standing by those who care about cancer through addressing the diverse needs of #ONEoncologycommunity, offering #educationforLIFE, and advocating for #accessiblecancerCARE. www.esmo.org